Last reviewed · How we verify
NCT06287645
Color Fundus Photograph With Experts Labelling
trial testing Color Fundus Photography/Non-Mydriatic Opthalmic Cameras in Retinal Disease in 50,000 participants. Currently enrolling.
31 December 2025
Quick facts
| Lead sponsor | Pakistan Council of Scientific and Industrial Research |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 50,000 |
| Start date | 12 May 2022 |
| Primary completion | 31 December 2025 |
| Estimated completion | 30 June 2026 |
| Sites | 1 location across Pakistan |
Drugs / interventions tested
- Color Fundus Photography/Non-Mydriatic Opthalmic Cameras
Conditions studied
- Retinal Disease — all drugs for Retinal Disease →
- Diabetic Retinopathy — all drugs for Diabetic Retinopathy →
Sponsor
Pakistan Council of Scientific and Industrial Research
Who can join
20 and older, any sex, with Retinal Disease or Diabetic Retinopathy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This trial aims to provide a digital retinal image dataset from Pakistan, graded by three specialists according to the severity of Diabetic Retinopathy. The dataset aims to improve research and patient care.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06287645
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Color Fundus Photography/Non-Mydriatic Opthalmic Cameras
Trials testing the same drug.
- NCT05471986 — Multicenter Diagnostic Clinical Performance Study For Automated Detection of Diabetic Retinopathy · unknown
Other recruiting trials for Retinal Disease
Currently open trials in the same condition.
- NCT07149740 — Data Gathering for A10900 · recruiting
- NCT06852963 — A Repeat-Dose, Open-Label, Two Arm Safety and Efficacy Study of Two Doses of VP-001 Administered Intravitreally in Parti · Phase 1, PHASE2 · recruiting
- NCT05699096 — Perfluorooctyl Bromide Which Empowers the Liquid to Flat the Detached Retina and Displace the Underneath Fluids Anterior · recruiting
- NCT06289452 — Safety and Efficacy Study of IVB102 Injection in Subjects With X-linked Retinoschisis · EARLY_PHASE1 · active not recruiting
- NCT06520410 — Safety and Efficacy of 18 mm Short Vitrectomy Probe for Pediatric Vitreoretinal Surgeries · Phase 4 · recruiting
Other Pakistan Council of Scientific and Industrial Research trials
Trials by the same sponsor.
- NCT05883072 — Exploring the Effectiveness of AI Generative Models for Diabetic Patients · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06287645 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Pakistan Council of Scientific and Industrial Research
- Last refreshed: 7 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06287645.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing